Device Biosurgical

Surgicel Nu-Knit

Payments companies reported to CMS as associated with Surgicel Nu-Knit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.5Massociated payments (2023-2025)

5,021clinicians with associated payments

5companies reporting

By year

2023 $430K

2024 $480K

2025 $602K

Payments reported as associated with Surgicel Nu-Knit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $435K

Physician Assistant $288K

Gynecologic Oncology $175K

Surgery $167K

Vascular Surgery $56K

Nurse Practitioner $45K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Surgicel Nu-Knit

These are the largest totals companies reported as associated with Surgicel Nu-Knit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Stephen Ingram	Austin, TX	Physician Assistant	$174,722.23
Jonathan Black	Miramar, FL	Gynecologic Oncology	$153,085.23
Faraz Kerendi	Austin, TX	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$149,695.88
Grayson Wheatley	Nashville, TN	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$137,013.62
Heather Austin	Salinas, CA	Physician Assistant	$57,468.93
Richard Nguyen	Los Gatos, CA	Surgery	$53,010.00
Sagar Gandhi	Greenville, SC	Vascular Surgery	$41,460.02
Mark Anderson	Philadelphia, PA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$40,419.99
Alissa Helvik	Coeur D Alene, ID	Nurse Practitioner	$37,411.97
Adnan Alseidi	Seattle, WA	Surgery	$29,296.77

Prescribed Surgicel Nu-Knit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.